+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aerie Pharmaceuticals - logo

Aerie Pharmaceuticals is a company that focuses on the development and commercialization of therapies for the treatment of glaucoma and other eye diseases. The National Eye Institute expects the number of people in the United States suffering from glaucoma to reach 4.3 million by 2030. Aerie was founded in 2005 and went in public in 2013, raising $67 million in its IPO. Its product candidates include Rhopressa and Roclatan. The company is headquartered in Irvine, California.

Ocular Drug Delivery Market Report 2025 - Product Thumbnail Image

Ocular Drug Delivery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Glaucoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Glaucoma Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
Optic Nerve Disorders Treatment Market Report 2025 - Product Thumbnail Image

Optic Nerve Disorders Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antiglaucoma Drugs Market Report 2025 - Product Thumbnail Image

Antiglaucoma Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Macular Degeneration Treatment Market Report 2025 - Product Thumbnail Image

Macular Degeneration Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Ophthalmic Drugs Market Report 2025 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Ocular Hypertension Treatment Market Report 2025 - Product Thumbnail Image

Ocular Hypertension Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator